Clinical Trials Browser

Phase 1 × Leiomyosarcoma × PTC596 × Clear all

NCT03761095 2024-03-15

A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)

Phase 1 Completed

Leiomyosarcoma